Ruth Luthi-Carter Selected Research

Ruth Luthi-Carter Research Topics

Disease

37	Huntington Disease (Huntington's Disease) 01/2020 - 06/2002
8	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 05/2007
6	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 10/2008
2	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 01/2022 - 01/2021
2	Dementia (Dementias) 01/2022 - 01/2021
2	Cognitive Dysfunction 02/2016 - 03/2011
2	Atrophy 12/2011 - 11/2007
2	Disease Progression 08/2011 - 04/2009
1	Multiple System Atrophy 10/2023
1	Parkinson Disease (Parkinson's Disease) 10/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2023
1	Inborn Genetic Diseases (Disease, Hereditary) 02/2016
1	Hypoxia (Hypoxemia) 05/2014
1	Temporal Lobe Epilepsy 01/2013
1	Neoplasms (Cancer) 01/2013
1	Nervous System Diseases (Neurological Disorders) 01/2013
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2013
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 10/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 03/2011
1	Myeloid Leukemia (Leukemia, Myelocytic) 05/2009
1	Ischemia 05/2009
1	Virus Diseases (Viral Diseases) 09/2008
1	Body Weight (Weight, Body) 10/2003
1	Progressive Myoclonic Epilepsies (Progressive Myoclonic Epilepsy) 08/2002

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 02/2016 - 08/2002
10	polyglutamineIBA 02/2016 - 08/2002
4	Huntingtin ProteinIBA 11/2013 - 08/2002
3	Messenger RNA (mRNA)IBA 08/2010 - 12/2003
2	TubulinIBA 01/2022 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 09/2007
2	Sirtuin 1IBA 06/2014 - 12/2011
2	Kainic Acid (Kainate)IBA 05/2014 - 01/2013
2	Butyric Acid (Butanoic Acid)IBA 02/2013 - 10/2003
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2013 - 10/2003
2	Histones (Histone)IBA 01/2013 - 01/2012
2	Amyloid beta-PeptidesIBA 07/2010 - 10/2008
1	SynucleinsIBA 10/2023
1	LigandsIBA 10/2023
1	Monoclonal AntibodiesIBA 01/2023
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2023
1	tau Proteins (tau Protein)IBA 01/2022
1	ThiazolesIBA 01/2016
1	Oxygen (Dioxygen)IBA 05/2014
1	CytokinesIBA 03/2014
1	GlucansIBA 03/2014
1	Small Interfering RNA (siRNA)IBA 03/2014
1	Therapeutic UsesIBA 02/2013
1	Mitogen-Activated Protein KinasesIBA 02/2013
1	Dual Specificity Phosphatase 1IBA 02/2013
1	MicroRNAs (MicroRNA)IBA 01/2013
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2013
1	GTP-Binding Proteins (G-Protein)IBA 01/2013
1	CaspasesIBA 01/2013
1	Mitogen-Activated Protein Kinase 14IBA 01/2013
1	ChromatinIBA 08/2011
1	Sirtuin 2IBA 06/2011
1	CholesterolIBA 06/2011
1	Protein AggregatesIBA 03/2011
1	Dopamine (Intropin)FDA LinkGeneric 03/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 03/2011
1	Peptide Hydrolases (Proteases)FDA Link 07/2010
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 07/2010
1	HippocalcinIBA 10/2009
1	CalciumIBA 10/2009
1	ClathrinIBA 05/2009
1	epsinIBA 05/2009
1	Vesicular Transport Adaptor ProteinsIBA 05/2009
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2009
1	Amyloid (Amyloid Fibrils)IBA 10/2008
1	Peptides (Polypeptides)IBA 10/2008
1	RNA (Ribonucleic Acid)IBA 09/2008
1	enhanced green fluorescent proteinIBA 09/2008
1	Glutamic Acid (Glutamate)FDA Link 11/2007
1	N-acetylaspartate (N-acetyl aspartate)IBA 11/2007
1	Neuroprotective AgentsIBA 11/2007
1	CreatineIBA 11/2007
1	Nucleosomes (Nucleosome)IBA 05/2007
1	Glutamine (L-Glutamine)FDA Link 05/2007
1	Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA 01/2005
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2003
1	Histone Deacetylase InhibitorsIBA 10/2003
1	VaccinesIBA 05/2003
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2002
1	Dopamine Receptors (Dopamine Receptor)IBA 06/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 09/2007
1	Synchrotrons 10/2011
1	Drug Therapy (Chemotherapy) 10/2003